SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : North American Vaccine
NVX 1.310-7.1%12:26 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: andy harrison who wrote (6)9/30/1996 8:06:00 PM
From: Don W Stone   of 82
 
Andy, You are absolutely right on.
I see from the Dow Jones news wire that NVX also mentioned their DTaP-IPV-HIB vaccine. I would assume in the company release there is more information on this.
The approval by Denmark of the DTaP-IPV vaccine does make a statement about NVX's leadership in combinant vaccine technology.

Perhaps all this will shift the focus on the street to what this little company is really all about. Specifically, that they just could become the dominant player in the pediatric vaccine business in a few short years IMHO. :-}
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext